975TiP Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma
| Autor: | Le, X., Gluck, I., Maurice-Dror, C., Panwar, A., Gold, K., Berlin, J., Dai, T., Grewal, J., Nagasaka, M., Rosenberg, A., Haigentz, M., Jr., Le Tourneau, C., Moreno, I., McDevitt, M., Patel, M., Da Costa, D., Lambert, S., Li, Y., Blaney, M., Gillison, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S685-S685 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|